keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Avibactam sodium (NXL-104) 是一种可逆的 β-内酰胺酶抑制剂,抑制 TEM-1,P99和KPC-2 β-内酰胺酶,IC50分别为8、80和38 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 279 | 现货 | ||
5 mg | ¥ 453 | 现货 | ||
10 mg | ¥ 659 | 现货 | ||
25 mg | ¥ 1,150 | 现货 | ||
50 mg | ¥ 1,860 | 现货 | ||
100 mg | ¥ 2,920 | 现货 | ||
200 mg | ¥ 4,230 | 现货 | ||
500 mg | ¥ 6,590 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 578 | 现货 |
产品描述 | Avibactam sodium (NXL-104) is a reversible β-lactamase inhibitor (IC50: 8/80/38 nM, for TEM-1/P99/KPC-2 β-lactamases). |
靶点活性 | TEM1:8 nM, P99:80 nM, KPC2:38 nM |
体外活性 | Avibactam (NXL104) sodium has little antibacterial activity and inhibits class A and C β-lactamases. Except for Metallo types and Acinetobacter OXA carbapenemases, Avibactam inactivates the most of important β-lactamases[2]. |
体内活性 | Avibactam sodium displays a slow return of activity with an off-rate of 0.045±0.022 min-1, which converts to a residence time half-life (tt1/2) of 16±8 min. Avibactam has slow deacylation through hydrolysis or reversibility, and this is in contrast to previously reported extremely long t1/2 values of >1 or >7 d for Avibactam inhibition of TEM-1[1]. Mice are infected with ca.106 CFU of Pseudomonas aeruginosa intramuscularly into the thigh or intranasally to cause pneumonia and are given 8 different (single) subcutaneous doses of Ceftazidime and Avibactam in various combined concentrations, ranging from 1 to 128 mg/kg of body weight in 2-fold increases. The mean estimated half-life in plasma of Ceftazidime in the terminal phase is 0.28 h (SD, 0.02 h), and that of Avibactam is 0.24 h (SD, 0.04 h). Volumes of distribution are 0.80 L/kg (SD, 0.14 L/kg) and 1.18 liters/kg (SD, 0.34 L/kg), respectively. |
激酶实验 | In a 200 μL reaction volume, 1 μM TEM-1 is incubated with and without 5 μM Avibactam for 5 min at 37°C and subjected to two ultrafiltration cartridge (UFC) steps to remove excess inhibitor (Ultrafree-0.5 with Biomax membrane, 5-kDa cutoff). Centrifugation at 10,600× g for 8 min is performed at 4°C. After each ultrafiltration step, 20 μL retentate is diluted with 180 μL assay buffer to restore the original enzyme concentration. After two UFC treatments, the amount of free Avibactam is quantified by LC/MS/MS and found to be <5% of the original concentration. Loss of protein during UFC is assessed by measuring TEM-1 activity (on 4,000-fold dilution) in the acyl-enzyme sample compare with a non-UFC-treated enzyme, and loss is found to be <5%[1]. |
细胞实验 | Avibactam is prepared in sterile water[2].Cells (~109 cfu) from overnight broth culture are spread on Mueller-Hinton agar supplemented with either (i) Ceftaroline plus Avibactam (1 or 4 mg/L) at 1-16× the MICs or (ii) Ceftaroline at 1 or 4 mg/L plus Avibactam at 1-8× the concentration needed to reduce the Ceftaroline MIC to 1 or 4 mg/L. Colonies are counted after overnight incubation and representatives are retained[2]. |
动物实验 | Avibactam is reconstituted in sterile water to a stock solution of 5,120 mg/L and the further solution is prepared in Mueller-Hinton broth. Outbred female CD-1 mice, 7 to 8 weeks old and weighing 20 to 25 g, are used in the experiments. Eight dose combinations are used. For the thigh-infected animals, the combinations of Ceftazidime and Avibactam are 16/4, 8/1, 64/32, and 2/128 mg/kg. For the Lung-infected mice, combinations of 32/16, 4/2, 128/8, and 1/64 mg/kg of the respective constituents are used. These combinations are chosen in order to detect possible pharmacokinetic interactions between the two compounds (Ceftazidime and Avibactam) and to cover a wide range of doses of each compound. |
别名 | 阿维巴坦, AVE-1330A, 阿维巴坦钠, NXL-104 |
分子量 | 287.22 |
分子式 | C7H10N3NaO6S |
CAS No. | 1192491-61-4 |
keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 53 mg/mL (184.5 mM)
H2O: 52 mg/mL (181 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / H2O | 1 mM | 3.4817 mL | 17.4083 mL | 34.8165 mL | 87.0413 mL |
5 mM | 0.6963 mL | 3.4817 mL | 6.9633 mL | 17.4083 mL | |
10 mM | 0.3482 mL | 1.7408 mL | 3.4817 mL | 8.7041 mL | |
20 mM | 0.1741 mL | 0.8704 mL | 1.7408 mL | 4.3521 mL | |
50 mM | 0.0696 mL | 0.3482 mL | 0.6963 mL | 1.7408 mL | |
100 mM | 0.0348 mL | 0.1741 mL | 0.3482 mL | 0.8704 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Avibactam sodium 1192491-61-4 Microbiology/Virology Antibacterial Antibiotic 阿维巴坦 inhibit antibacterial Avibactam AVE-1330A NXL 104 Bacterial TEM-1 β-lactamase Inhibitor Klebsiella pneumonia Pseudomonas aeruginosa 阿维巴坦钠 NXL-104 NXL104 inhibitor